Elegibilidade Dos Contraceptivos para Mulheres Com Alto Risco de Infecção Pelo HIV. Diretriz : Recomendações Sobre o Uso de Métodos Contraceptivos Por Mulheres Com Alto Risco de Infecção Pelo HIV.
| Format: | eBook |
|---|---|
| Language: | Portuguese |
| Published: |
Geneva :
World Health Organization,
2020.
|
| Edition: | 1st ed. |
| Subjects: | |
| Online Access: | Click to View |
Table of Contents:
- Intro
- Acknowledgements
- Executive summary
- background
- Methods of guideline review and development
- 2.1 Guideline Development Group
- 2.2 Guideline development process
- 2.3 Evidence Retrieval
- 3.6 Additional evidence considered by the GDG
- 3.6.1 Biological data
- 3.4 Intrauterine devices
- 3.3 Progestogen-only pills
- 3.2 Progestogen-only implants
- 3.1 Progestogen-only injectables
- 2.5 Recommendation formulation
- 2.4 Evidence Synthesis
- 4.2 Rationale
- 4.1 Recommendations for contraceptive use among women at high risk of HIV infection
- 3.6.2 Values and preferences of contraceptive users
- 3.5 Combined hormonal contraceptives
- Implications for policy-makers, programme managers and health-care providers
- 5.1 A woman's risk of HIV should not restrict her contraceptive choice
- 5.2 Efforts to expand access to contraceptive options must continue
- 5.3 A renewed emphasis on HIV and STI prevention services is urgently needed
- 6.1 Contraceptive methods and HIV acquisition
- 6.2 HIV prevention
- 6.4 Increased funding for high-quality, policy-relevant research
- 6.3 Community involvement
- References
- Annex 1. Guideline Development Group and evidence secretariat
- Annex 2. Declarations of conflicts of interest
- Annex 3. GRADE evidence profiles
- Annex 4. Evidence-to- decision table for hormonal contraceptive methods and intrauterine devices (IUDs)
- Annex 5: Systematic reviews.